beta corona virus vaccine (Tiba Biotech)

N/A

Report date: 2025/12/18 17:46:39

Base Information

Drug Namebeta corona virus vaccine (Tiba Biotech)
Drug Alias NameSARS-CoV-2 vaccine (Tiba Biotech/KAUST)MERS-CoV vaccine (Tiba Biotech/KAUST)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSaudi Arabia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTiba Biotech LLC
China Registration ClassN/A

Develop Information

Active CompaniesTiba Biotech LLCKing Abdullah University of Science and Technology
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Coronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A